Catalyst Crew Technologies Corp. Announces Transformational Change in Control and Acquisition of AI Healthcare Assets

Key Highlights

• Change in Control: Catalyst Crew Technologies Corp. (“the Company”) has undergone a significant change in control following the acquisition of key artificial intelligence healthcare assets and related technology.
• Transition to Digital Health: The Company is transitioning from a shell company to a digital health technology company focused on AI-driven healthcare analytics, telehealth infrastructure, and hybrid home-based medical services.
• Asset Acquisition: The Company acquired intellectual property and assets associated with an AI-enabled healthcare analytics system and a technology-enabled services coordination platform in exchange for 12,000,000 shares of restricted common stock.
• Change of Corporate Name and Symbol Planned: The Company intends to change its corporate name and trading symbol to reflect its new business direction, subject to Board, state, and FINRA approval.
• No Revenue and Development Stage: The Company is currently pre-revenue, in the development stage, and has no employees other than its sole officer and director.
• Majority Ownership: Post-transaction, a single majority stockholder controls over 71% of the Company’s outstanding common stock.
• Risks & Uncertainties: The Company faces substantial risks, including limited operating history, need for additional capital, regulatory uncertainties, AI validation, data privacy, and cybersecurity concerns.

Details for Investors

Strategic Shift: From Shell Company to Digital Health Innovator

Catalyst Crew Technologies Corp. has executed a dramatic strategic shift following a change in control and the acquisition of advanced healthcare technology assets. The Company, previously classified as a “shell company” under SEC Rule 12b-2, is now positioning itself as a digital health technology enterprise. The Company’s new focus is on integrating artificial intelligence-driven healthcare analytics, telehealth capabilities, and hybrid, home-based medical services.

Asset Acquisition: Material Terms and Structure

On February 17, 2026, Catalyst Crew Technologies Corp. entered into an Asset Purchase Agreement under which it acquired proprietary software code, analytical models, and related intellectual property. These assets include:

• An artificial intelligence-enabled healthcare analytics system (“AI Healthcare Platform”).
• A technology-enabled healthcare services coordination platform.

As consideration, the Company issued 12,000,000 shares of restricted common stock to the seller, Kevin Rodavy, who is now also the Company’s sole officer and director. Importantly, the Company did not assume any liabilities as part of this transaction.

Implications for Shareholders

• Change of Control: The transaction resulted in a change of control. The new majority stockholder, Kevin Rodavy, now beneficially owns approximately 71.1% of the Company’s outstanding common stock through direct holdings and the stock issued via the asset purchase.
• Potential Name and Symbol Change: The Company intends to change its name and trading symbol to better reflect its new business model. This is subject to approval by the Board of Directors, the Nevada Secretary of State, and FINRA. The timing and certainty of these changes are not guaranteed.
• Outstanding Shares: Following the transaction, the Company has 56,296,895 shares of common stock issued and outstanding. There are no shares of preferred stock issued or outstanding, though the Company is authorized to issue up to 1 billion shares of capital stock (700 million common, 300 million preferred).

Financial Condition and Risk Factors

• Development Stage: The Company is in the development stage, has not generated any revenue, and has incurred recurring operating losses.
• Need for Capital: Significant capital will be required for ongoing software development, regulatory compliance, infrastructure, cybersecurity, marketing, and potential international expansion. There is substantial doubt about the Company’s ability to continue as a going concern unless additional capital is raised.
• Material Weaknesses in Internal Controls: The Company has identified material weaknesses in its internal controls due to limited accounting personnel and lack of segregation of duties. Remediation will require additional resources.
• No Employees: As of the report date, the Company has no employees other than its sole officer and director.
• Stock Liquidity and Volatility: The Company’s common stock is quoted on OTC Markets under the symbol CCTC. Trading volume is limited and may be sporadic, with significant price volatility possible due to the Company’s development-stage status and lack of revenue.
• No Dividends: The Company has never paid dividends and does not anticipate doing so in the foreseeable future.
• Future Dilution Risk: Additional capital may be raised by issuing more shares, which could dilute current stockholders.
• Regulatory and Operational Risks: The Company faces risks related to regulatory approval, validation of AI models, market acceptance, cybersecurity, data privacy, and international expansion.

Other Noteworthy Matters

• No Material Legal Proceedings: The Company is not currently involved in any material legal proceedings.
• Off-Balance Sheet Arrangements: The Company does not have any off-balance sheet arrangements.
• Recent Sales of Unregistered Securities: The 12,000,000 shares issued in the asset purchase are restricted securities, issued under Section 4(a)(2) of the Securities Act in a private transaction to an accredited investor, and cannot be resold absent registration or a valid exemption.

Conclusion: Significant Transformation and High Uncertainty

This Form 8-K filing represents a transformational moment for Catalyst Crew Technologies Corp. The Company has moved from being a shell company to an ambitious entrant in the digital health and AI-powered healthcare analytics market. While the acquisition of advanced technology assets provides a potential foundation for future growth, investors should be aware of the high degree of risk, the early stage of development, lack of revenue, and the need for substantial additional capital. The change in control, planned rebranding, and future dilution risks are material factors that could impact share value and volatility in the near and intermediate term.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial professionals before making investment decisions. The Company is at an early stage with substantial risks, and past performance is not indicative of future results.

View Catalyst Crew Technologies Corp. Historical chart here